doi: 10.1016/j.brainresbull.2022.09.003 159 DaiYZhangLYuJZhouXHeHJiYet al
"Our study also underlines the current challenges with treating type 2 diabetes and obesity with these highly effective medications, as only 4 in 10 patients in our cohort had persistent medication coverage at one year," Gasoyan told Newsweek
Dietary habits and meal composition: Eating patterns significantly influence symptom onset
CWWLS: Clients have been extremely happy with results they have received, and many have already met their weight loss goals
GLP-1, or glucagon-like peptide-1, enhances insulin secretion, inhibits glucagon release, and slows gastric emptying, leading to reduced appetite and increased satiety
Some individuals may experience a gradual weight regain after stopping semaglutide GLP-1, while others may maintain their reduced weight